Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hardré R[au]:

Search results

Items: 31

1.

Ruminococcin C, a promising antibiotic produced by a human gut symbiont.

Chiumento S, Roblin C, Kieffer-Jaquinod S, Tachon S, Leprètre C, Basset C, Aditiyarini D, Olleik H, Nicoletti C, Bornet O, Iranzo O, Maresca M, Hardré R, Fons M, Giardina T, Devillard E, Guerlesquin F, Couté Y, Atta M, Perrier J, Lafond M, Duarte V.

Sci Adv. 2019 Sep 25;5(9):eaaw9969. doi: 10.1126/sciadv.aaw9969. eCollection 2019 Sep.

2.

Efficient Light-Driven Hydrogen Evolution Using a Thiosemicarbazone-Nickel (II) Complex.

Panagiotakis S, Landrou G, Nikolaou V, Putri A, Hardré R, Massin J, Charalambidis G, Coutsolelos AG, Orio M.

Front Chem. 2019 Jun 27;7:405. doi: 10.3389/fchem.2019.00405. eCollection 2019.

3.

Hydrogen Evolution Reactions Catalyzed by a Bis(thiosemicarbazone) Cobalt Complex: An Experimental and Theoretical Study.

Straistari T, Hardré R, Fize J, Shova S, Giorgi M, Réglier M, Artero V, Orio M.

Chemistry. 2018 Jun 21;24(35):8779-8786. doi: 10.1002/chem.201801155. Epub 2018 Jun 6.

PMID:
29637648
4.

New insight into the allosteric effect of L-tyrosine on mushroom tyrosinase during L-dopa production.

Hassani S, Gharechaei B, Nikfard S, Fazli M, Gheibi N, Hardré R, Legge RL, Haghbeen K.

Int J Biol Macromol. 2018 Jul 15;114:821-829. doi: 10.1016/j.ijbiomac.2018.03.185. Epub 2018 Apr 3.

PMID:
29621499
5.

2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors.

Haudecoeur R, Carotti M, Gouron A, Maresca M, Buitrago E, Hardré R, Bergantino E, Jamet H, Belle C, Réglier M, Bubacco L, Boumendjel A.

ACS Med Chem Lett. 2016 Nov 17;8(1):55-60. doi: 10.1021/acsmedchemlett.6b00369. eCollection 2017 Jan 12.

6.

Recombinant Tyrosinase from Polyporus arcularius: Overproduction in Escherichia coli, Characterization, and Use in a Study of Aurones as Tyrosinase Effectors.

Marková E, Kotik M, Křenková A, Man P, Haudecoeur R, Boumendjel A, Hardré R, Mekmouche Y, Courvoisier-Dezord E, Réglier M, Martínková L.

J Agric Food Chem. 2016 Apr 13;64(14):2925-31. doi: 10.1021/acs.jafc.6b00286. Epub 2016 Mar 31.

PMID:
26961852
7.

Are Human Tyrosinase and Related Proteins Suitable Targets for Melanoma Therapy?

Buitrago E, Hardré R, Haudecoeur R, Jamet H, Belle C, Boumendjel A, Bubacco L, Réglier M.

Curr Top Med Chem. 2016;16(27):3033-3047. Review.

PMID:
26881706
8.

Reactivity of dinuclear copper(II) complexes towards melanoma cells: Correlation with its stability, tyrosinase mimicking and nuclease activity.

Nunes CJ, Borges BE, Nakao LS, Peyroux E, Hardré R, Faure B, Réglier M, Giorgi M, Prieto MB, Oliveira CC, Da Costa Ferreira AM.

J Inorg Biochem. 2015 Aug;149:49-58. doi: 10.1016/j.jinorgbio.2015.05.007. Epub 2015 May 19.

PMID:
26021698
9.

Exploring the interaction of N/S compounds with a dicopper center: tyrosinase inhibition and model studies.

Buitrago E, Vuillamy A, Boumendjel A, Yi W, Gellon G, Hardré R, Philouze C, Serratrice G, Jamet H, Réglier M, Belle C.

Inorg Chem. 2014 Dec 15;53(24):12848-58. doi: 10.1021/ic501829s. Epub 2014 Nov 21.

PMID:
25415587
10.

Investigation of binding-site homology between mushroom and bacterial tyrosinases by using aurones as effectors.

Haudecoeur R, Gouron A, Dubois C, Jamet H, Lightbody M, Hardré R, Milet A, Bergantino E, Bubacco L, Belle C, Réglier M, Boumendjel A.

Chembiochem. 2014 Jun 16;15(9):1325-33. doi: 10.1002/cbic.201402003. Epub 2014 May 21.

PMID:
24849818
11.

Unsymmetrical binding modes of the HOPNO inhibitor of tyrosinase: from model complexes to the enzyme.

Bochot C, Favre E, Dubois C, Baptiste B, Bubacco L, Carrupt PA, Gellon G, Hardré R, Luneau D, Moreau Y, Nurisso A, Réglier M, Serratrice G, Belle C, Jamet H.

Chemistry. 2013 Mar 11;19(11):3655-64. doi: 10.1002/chem.201202643. Epub 2013 Jan 29.

PMID:
23362183
12.

Versatile effects of aurone structure on mushroom tyrosinase activity.

Dubois C, Haudecoeur R, Orio M, Belle C, Bochot C, Boumendjel A, Hardré R, Jamet H, Réglier M.

Chembiochem. 2012 Mar 5;13(4):559-65. doi: 10.1002/cbic.201100716. Epub 2012 Feb 3.

PMID:
22307818
13.

The versatile binding mode of transition-state analogue inhibitors of tyrosinase towards dicopper(II) model complexes: experimental and theoretical investigations.

Orio M, Bochot C, Dubois C, Gellon G, Hardré R, Jamet H, Luneau D, Philouze C, Réglier M, Serratrice G, Belle C.

Chemistry. 2011 Nov 25;17(48):13482-94. doi: 10.1002/chem.201100665. Epub 2011 Oct 25.

PMID:
22025275
14.

Refinement of arylthiosemicarbazone pharmacophore in inhibition of mushroom tyrosinase.

Yi W, Dubois C, Yahiaoui S, Haudecoeur R, Belle C, Song H, Hardré R, Réglier M, Boumendjel A.

Eur J Med Chem. 2011 Sep;46(9):4330-5. doi: 10.1016/j.ejmech.2011.07.003. Epub 2011 Jul 8.

PMID:
21777998
15.

Probing the peptidylglycine alpha-hydroxylating monooxygenase active site with novel 4-phenyl-3-butenoic acid based inhibitors.

Langella E, Pierre S, Ghattas W, Giorgi M, Réglier M, Saviano M, Esposito L, Hardré R.

ChemMedChem. 2010 Sep 3;5(9):1568-76. doi: 10.1002/cmdc.201000214.

PMID:
20715282
16.

Binding of 2-hydroxypyridine-N-oxide on dicopper(II) centers: insights into tyrosinase inhibition mechanism by transition-state analogs.

Peyroux E, Ghattas W, Hardré R, Giorgi M, Faure B, Simaan AJ, Belle C, Réglier M.

Inorg Chem. 2009 Dec 7;48(23):10874-6. doi: 10.1021/ic901593x.

PMID:
19883108
17.

Pathway for the stereocontrolled Z and E production of alpha,alpha-difluorine-substituted phenyl butenoates.

Ghattas W, Hess CR, Iacazio G, Hardré R, Klinman JP, Réglier M.

J Org Chem. 2006 Oct 27;71(22):8618-21.

PMID:
17064042
18.

Mono, di and tri-mannopyranosyl phosphates as mannose-1-phosphate prodrugs for potential CDG-Ia therapy.

Hardré R, Khaled A, Willemetz A, Dupré T, Moore S, Gravier-Pelletier C, Le Merrer Y.

Bioorg Med Chem Lett. 2007 Jan 1;17(1):152-5. Epub 2006 Oct 17.

PMID:
17049852
19.

Superoxide dismutase-like activity of cobalt(II) complexes based on a sugar platform.

Bellot F, Hardré R, Pelosi G, Thérisod M, Policar C.

Chem Commun (Camb). 2005 Nov 21;(43):5414-6. Epub 2005 Sep 30.

PMID:
16261231
20.

The impact of pyrrolidine hydroxylation on the conformation of proline-containing peptides.

Taylor CM, Hardré R, Edwards PJ.

J Org Chem. 2005 Feb 18;70(4):1306-15.

PMID:
15704965
21.

The structures of inhibitor complexes of Pyrococcus furiosus phosphoglucose isomerase provide insights into substrate binding and catalysis.

Berrisford JM, Akerboom J, Brouns S, Sedelnikova SE, Turnbull AP, van der Oost J, Salmon L, Hardré R, Murray IA, Blackburn GM, Rice DW, Baker PJ.

J Mol Biol. 2004 Oct 22;343(3):649-57.

PMID:
15465052
22.

Leishmania mexicana mexicana glucose-6-phosphate isomerase: crystallization, molecular-replacement solution and inhibition.

Cordeiro AT, Hardré R, Michels PA, Salmon L, Delboni LF, Thiemann OH.

Acta Crystallogr D Biol Crystallogr. 2004 May;60(Pt 5):915-9. Epub 2004 Apr 21.

PMID:
15103138
23.

Factors affecting conformation in proline-containing peptides.

Taylor CM, Hardré R, Edwards PJ, Park JH.

Org Lett. 2003 Nov 13;5(23):4413-6.

PMID:
14602013
24.

Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma brucei.

Pasti C, Rinaldi E, Cervellati C, Dallocchio F, Hardré R, Salmon L, Hanau S.

Bioorg Med Chem. 2003 Apr 3;11(7):1207-14.

PMID:
12628648
25.

The crystal structure of rabbit phosphoglucose isomerase complexed with 5-phospho-D-arabinonohydroxamic acid.

Arsenieva D, Hardre R, Salmon L, Jeffery CJ.

Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):5872-7.

26.

A convenient preparation of aldonohydroxamic acids in water and crystal structure of L-erythronohydroxamic acid.

Salmon L, Prost E, Merienne C, Hardré R, Morgant G.

Carbohydr Res. 2001 Oct 8;335(3):195-204.

PMID:
11578635
27.
28.

Competitive inhibition of Trypanosoma brucei phosphoglucose isomerase by D-arabinose-5-phosphate derivatives.

Hardré R, Salmon L, Opperdoes FR.

J Enzyme Inhib. 2000;15(5):509-15.

PMID:
11030090
29.

Structure of the human oxytocinase/insulin-regulated aminopeptidase gene and localization to chromosome 5q21.

Rasmussen TE, Pedraza-Díaz S, Hardré R, Laustsen PG, Carríon AG, Kristensen T.

Eur J Biochem. 2000 Apr;267(8):2297-306.

31.

Synthesis and evaluation of a new inhibitor of phosphoglucose isomerases: the enediolate analogue 5-phospho-D-arabinohydroxamate.

Hardré R, Bonnette C, Salmon L, Gaudemer A.

Bioorg Med Chem Lett. 1998 Dec 1;8(23):3435-8.

PMID:
9873748

Supplemental Content

Loading ...
Support Center